Mayo Clinic Endocrine Update 2021 is a conference dedicated to best practices, barriers to optimal patient outcomes and new approaches to evaluation and management of complex and common endocrine and metabolic disorders.
Topics
- Potential complications with the use of SGLT 2 inhibitors
- Improving cardiovascular outcomes of an idetified patient who would benefit from SGLT 2 inhibitors in the management of Type 2 diabetes
- Endocrine-related adverse effects of immune checkpoint inhibitors for both clinical and diagnostic approaches
- The indications for immune checkpoint inhibitors in cancer therapies
- The genomics of medullary thyroid cancer
- Treatment strategies for checkpoint-induced endocrinopathies
- Treatment strategies for patients with MTC, when to start systemic therapy, which drug to use first, and salvage therapy options for treatment of refractory disease
- Current and recently approved systemic treatment options for patients with advanced medullary thyroid cancer
- Factors that contribute to bone loss after bariatric surgery to prevent metabolic bone disease
Who should Attend
Practicing endocrinologists, endocrine surgeons and internists who care for patients with endocrine disorders.
